While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.5 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.81 per share a year ago.
Intuitive Surgical on Tuesday beat Wall Street estimates for first-quarter profit and revenue, as the firm rode the wave of robust demand for its minimally invasive surgical robots used in complex medical procedures.
ISRG expects its addressable procedures to reach 9 million by 2026, pointing to a significant growth runway as robotic surgery adoption remains nascent.
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) reports Q1 2026 results on April 21 after the bell.
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $458.08, moving 2.19% from the previous trading session.
Intuitive Surgical faces a key test as earnings near, with strong procedure growth and da Vinci 5 adoption offset by pricing pressure and valuation concerns.
Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $467.22, indicating a +1.8% shift from the previous trading day.
ISRG slides nearly 20% YTD despite strong procedure growth and upgrades, as valuation concerns and macro pressures weigh on near-term upside.
Intuitive Surgical's 13-15% 2026 procedure growth signals durable demand and global expansion, but macro and policy risks could test its premium valuation.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $462.28, marking a +2.06% move from the previous day.